10.24335/L17323
RoyaltyStat
Exclusive patent and know-how license to make, have made, use, develop, formulate, sell, import and sublicense pharmaceutical compositions containing compounds designated 1263W94 and/or GW275175X, for the treatment, palliation and prevention in humans of cytomegalovirus infections related to transplant, including solid organ and hematopoietic stem cell transplantation, congenital transmission, and HIV, and excluding treatment of HSV-1, HSV-2, Epstein Barr and Varicella Zoster Virus, HHV-6, HHV-7, HHV-8, lymphoproliferative disease, multiple sclerosis, chronic fatigue syndrome, or primary atherosclerosis.
RoyaltyStat
2003